172 Everolimus Treatment Reduces the Need for Anti-CMV Prophylaxis in De Novo Heart Transplant Recipients

2011 ◽  
Vol 30 (4) ◽  
pp. S64 ◽  
Author(s):  
L. Potena ◽  
I.G. Bianchi ◽  
C. D'Agostino ◽  
D. Abate ◽  
G. Magnani ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Transplant Recipients ◽  
Heart Transplant Recipients ◽  
Cmv Prophylaxis

Single-centre first experience with everolimus and CSA for de novo heart transplant recipients

2005 ◽  
Vol 53 (S 3) ◽  
Author(s):  
H Lehmkuhl ◽  
M Dandel ◽  
C Knosalla ◽  
O Grauhan ◽  
M Jurmann ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Transplant Recipients ◽  
Single Centre ◽  
Heart Transplant Recipients

Cardiac Allograft Vasculopathy: Differences in De Novo and Maintenance Heart Transplant Recipients

2006 ◽  
Vol 82 (Supplement) ◽  
pp. S5-S12 ◽  
Author(s):  
Maria Frigerio ◽  
Andrea Garascia ◽  
Elena Roubina ◽  
Giada Distefano ◽  
Pedro Silva Orrego ◽  
...  
Keyword(s):  
Heart Transplant ◽  
De Novo ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Transplant Recipients ◽  
Allograft Vasculopathy ◽  
Heart Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document